3 Reasons to Avoid JBI and 1 Stock to Buy Instead

JBI Cover Image

Janus currently trades at $7.05 per share and has shown little upside over the past six months, posting a small loss of 4.1%.

Is there a buying opportunity in Janus, or does it present a risk to your portfolio? Get the full stock story straight from our expert analysts, it’s free.

Why Is Janus Not Exciting?

We're cautious about Janus. Here are three reasons why JBI doesn't excite us and a stock we'd rather own.

1. Slow Organic Growth Suggests Waning Demand In Core Business

Investors interested in Commercial Building Products companies should track organic revenue in addition to reported revenue. This metric gives visibility into Janus’s core business because it excludes one-time events such as mergers, acquisitions, and divestitures along with foreign currency fluctuations - non-fundamental factors that can manipulate the income statement.

Over the last two years, Janus’s organic revenue averaged 1.9% year-on-year growth. This performance was underwhelming and suggests it may need to improve its products, pricing, or go-to-market strategy, which can add an extra layer of complexity to its operations. Janus Organic Revenue Growth

2. Revenue Projections Show Stormy Skies Ahead

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Janus’s revenue to drop by 9.4%, a decrease from its 2.8% annualized declines for the past two years. This projection doesn't excite us and suggests its products and services will face some demand challenges.

3. EPS Trending Down

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Sadly for Janus, its EPS declined by 9.4% annually over the last four years while its revenue grew by 15.1%. This tells us the company became less profitable on a per-share basis as it expanded.

Janus Trailing 12-Month EPS (Non-GAAP)

Final Judgment

Janus isn’t a terrible business, but it isn’t one of our picks. That said, the stock currently trades at 18.3× forward price-to-earnings (or $7.05 per share). While this valuation is fair, the upside isn’t great compared to the potential downside. We're pretty confident there are more exciting stocks to buy at the moment. Let us point you toward the most entrenched endpoint security platform on the market.

Stocks We Like More Than Janus

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.

Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.